| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/30/2013 | CN102895134A Slimming warm-up oil |
| 01/30/2013 | CN101947315B Application of Chinese medicinal bitter apricot seeds in lysozyme sodium alginate microspheres |
| 01/30/2013 | CN101879156B Medicinal composition and application thereof |
| 01/30/2013 | CN101591288B Cytochalasin compounds and preparation method and application thereof |
| 01/30/2013 | CN101432295B Application of peptide from lactoprotein |
| 01/29/2013 | US8362274 Arylalkylamine compound and process for preparing the same |
| 01/29/2013 | US8362231 RNA interference mediating small RNA molecules |
| 01/29/2013 | US8362205 Delocalization molecules and use thereof |
| 01/29/2013 | US8362078 Method for reducing the severity of neurological disorders |
| 01/29/2013 | US8362058 Bicyclic compound, production and use thereof |
| 01/29/2013 | US8362009 Substituted diazepan orexin receptor antagonists |
| 01/29/2013 | US8361968 Metastin derivatives and use thereof |
| 01/29/2013 | US8361443 Peptide-based compounds |
| 01/29/2013 | CA2694410C Pyridinoylpiperidines as 5-ht1f agonists |
| 01/29/2013 | CA2507987C A vegetable composition having blood enhancing properties |
| 01/29/2013 | CA2460000C Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 01/29/2013 | CA2448665C Sustained-release analgesic compounds |
| 01/29/2013 | CA2431891C Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 01/29/2013 | CA2322160C Vaccines, immunotherapeutics and methods for using the same |
| 01/24/2013 | WO2013012670A1 Treatment for hypoxia |
| 01/24/2013 | WO2013012007A1 Anti-virus agent composition |
| 01/24/2013 | WO2013011932A1 Azabenzimidazole derivative having ampk-activating activity |
| 01/24/2013 | WO2013011841A1 Indirubin derivative having highly selective cytotoxicity for malignant tumors |
| 01/24/2013 | WO2013011458A1 A method of managing chemotherapy induced alopecia or cachexia or both |
| 01/24/2013 | WO2013010382A1 Heterocyclic substituted pyrimidine compound |
| 01/24/2013 | US20130024986 Transgenic plants with controlled distribution of a trait to progeny |
| 01/24/2013 | US20130024956 Antibodies to cd40 |
| 01/24/2013 | US20130023647 Modified human thymic stromal lymphopoietin |
| 01/24/2013 | US20130023517 Therapeutic methods employing substituted piperidines which are CCR3 antagonists |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130022679 Controlled Release and Taste Masking Oral Pharmaceutical Composition |
| 01/24/2013 | US20130022544 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
| 01/24/2013 | US20130022538 Aptamer-mrna conjugates for targeted protein or peptide expression and methods for their use |
| 01/24/2013 | CA2841954A1 Treatment for hypoxia |
| 01/24/2013 | CA2841906A1 Azabenzimidazole derivative having ampk-activating activity |
| 01/23/2013 | EP2548879A1 Crystal of diamine derivative and method of producing same |
| 01/23/2013 | EP2548872A1 Cyclopropanecarboxylic acid derivative |
| 01/23/2013 | EP2548871A1 Cycloalkyl-substituted imidazole derivative |
| 01/23/2013 | EP2548576A1 Diagnosis of cancer using anti-desmoglein-3 antibodies |
| 01/23/2013 | EP2548557A1 Reserpine to treat cognitive faults of the central nervous system |
| 01/23/2013 | CN102892882A Reducing agent from microorganism belonging to genus bacillus and application for same |
| 01/23/2013 | CN102892760A Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis |
| 01/23/2013 | CN102892423A Adiponectin production accelerating composition |
| 01/23/2013 | CN102888279A Extracting method of corn stigma essential oil |
| 01/23/2013 | CN102885964A Traditional Chinese medicine composition with effect on clearing summer-heat and preparation method thereof |
| 01/23/2013 | CN102885909A Waste-free method for extracting apple polyphenol |
| 01/23/2013 | CN102885830A Application of Gypensapogenin B to preparation of MAO (monoamine oxidase) inhibitor |
| 01/23/2013 | CN102885825A Application of Gypensapogenin A in preparation of monoamine oxidase (MAO) inhibitor |
| 01/23/2013 | CN102885822A Carboxylesterase inhibitor with tanshinone skeleton structure and application thereof |
| 01/23/2013 | CN102525909B Method for preparing penehyclidine hydrochloride injection |
| 01/23/2013 | CN102020607B 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 01/22/2013 | US8357670 Oligomeric compounds for the modulation of HIF-1A expression |
| 01/22/2013 | US8357399 Tamper-resistant oral opioid agonist formulations |
| 01/22/2013 | CA2699733C 6,11-bridged biaryl macrolides |
| 01/22/2013 | CA2646460C Treatment of poultry for reducing the feed conversion rate or for reducing the incidence of ascites |
| 01/22/2013 | CA2483525C Method of measuring neprilysin activity |
| 01/22/2013 | CA2441970C Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/22/2013 | CA2375619C Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 01/22/2013 | CA2343716C Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/22/2013 | CA2338524C Inhibitors of urokinase and blood vessel formation |
| 01/22/2013 | CA2329267C A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upflp, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 01/22/2013 | CA2325629C Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide |
| 01/17/2013 | WO2013009793A1 Chymase compositions, antibodies, diagnostics, and therapeutic methods related thereto |
| 01/17/2013 | WO2013008928A1 Macrolide derivative |
| 01/17/2013 | WO2013008872A1 Novel compound having parp inhibitory activity |
| 01/17/2013 | WO2013008681A1 Pharmaceutical composition for preventing or treating fibrosis |
| 01/17/2013 | WO2013007771A1 Method for the prevention and treatment of sepsis |
| 01/17/2013 | WO2013007700A1 Pharmaceutical composition comprising oleic acid, palmitic acid, linoleic acid and linolenic acid |
| 01/17/2013 | US20130018061 Method for Improving Exercise and Recovery From Exercise |
| 01/17/2013 | US20130018058 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 01/17/2013 | CA2842060A1 Method for the prevention and treatment of sepsis |
| 01/17/2013 | CA2841897A1 Novel compound having parp inhibitory activity |
| 01/16/2013 | EP2546255A1 Benzazepine compound |
| 01/16/2013 | EP2546234A1 Nitrogeneous heterocyclic derivative and medicine containing the same as an active ingredient |
| 01/16/2013 | EP2546231A1 Alkylamine derivative |
| 01/16/2013 | EP2545935A1 HLS-5, a control sumoylation agent |
| 01/16/2013 | EP2545926A1 Therapeutic agent and therapeutic device for alleviating ischemia-reperfusion injury |
| 01/16/2013 | EP2545924A1 Method for the prevention and treatment of sepsis. |
| 01/16/2013 | EP2544710A1 Immunogenic composition comprising s. pneumoniae polysaccharides conjugated to carrier proteins |
| 01/16/2013 | CN102884053A Cyclopropanecarboxylic acid derivative |
| 01/16/2013 | CN102884047A 2-pyridone compounds |
| 01/16/2013 | CN102883750A 选择性整联蛋白抑制剂 Selective integrin inhibitors |
| 01/16/2013 | CN102883733A AGE production inhibitor |
| 01/16/2013 | CN102883730A Therapeutic agent and therapeutic device for alleviating ischemia-reperfusion injury |
| 01/16/2013 | CN102883716A Dried plant tissue and plant tissue extract for ameliorating central nervous system degenerative diseases accompanied by learning/memory disorders, movement disorders and the like, and pharmaceutical agent and food or beverage each comprising the dri |
| 01/16/2013 | CN102876716A Lentiviral expression vector for specifically promoting hepatic cell CYP2E1 gene high expression, construction method of vector and application of vector |
| 01/16/2013 | CN102875681A Anti-alpha v beta 6 antibodies and uses thereof |
| 01/16/2013 | CN102875479A Quinazoline diketone derivative and preparation method, drug compound and application thereof |
| 01/16/2013 | CN102875478A Amine salts of a crth2 antagonist |
| 01/16/2013 | CN102872456A One dose vaccination with mycoplasma hyopneumoniae |
| 01/16/2013 | CN102872351A Medicament for treating thyroiditis and preparation method thereof |
| 01/16/2013 | CN102362855B Itraconazole isomer oral liquid |
| 01/16/2013 | CN102274476B Traditional Chinese medicine composition for treating phlegm retention |
| 01/16/2013 | CN101969961B Combined use of cholestanol derivative |
| 01/16/2013 | CN101948858B RNA (Ribose Nucleic Acid) interference recombination vector of SET (Patient SE Translocation) genes and establishment method and application thereof |
| 01/16/2013 | CN101878027B Multitarget compounds active at a PPAR and cannabinoid receptor |
| 01/16/2013 | CN101747253B Trisubstituted chiral lactam derivative and preparation method and application thereof |
| 01/16/2013 | CN101730690B Sulfonamide compound, and crystal thereof |
| 01/16/2013 | CN101610772B Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination |
| 01/15/2013 | CA2650577C Use of 12-imidazolyl-1-dodecanol or its pharmaceutically acceptable salts for producing a pharmaceutical preparation |